Table 2.
Pre vaccination |
Post vaccination |
||||
---|---|---|---|---|---|
Study; Subgroup | Testosterone level | 95 % CI | Testosterone level | 95 % CI | p value |
Testosterone | |||||
Rozhivanov, 2021 | 16.5 | 14.0–22.1 | 16.7 | 14.0–22.1 | |
Elagin, 2021 | 22.20 | 17.65–30.63 | 17.25 | 13.00–19.85 | |
Drapkina, 2021 | 9.60 | 8.30–12.8 | 11.80 | 9.40–13.2 | |
Pooled (95 % CI) | 15.15 | 9.37–24.48 | 14.88 | 11.18–19.82 | 0.635 |
I2 | 86.90 % | 89.40 % | |||
Spermatozoa concentration | Concentration | 95 % CI | Concentration | 95 % CI | |
Rozhivanov, 2021 | 70.0 | 51.0–112.0 | 71 | 53–102 | |
Elagin, 2021 | 86.00 | 49.75–117.25 | 103.00 | 59.0–116.0 | |
Drapkina, 2021 | 45.0 | 25.0–83.0 | 53.5 | 32.0–79.0 | |
Pooled (95 % CI) | 69.94 | 49.77–98.29 | 75.49 | 49.82–114.4 | 0.098 |
I2 | 42.70 % | 84.10 % | |||
Progressive Motility | Progressive Motility | 95 % CI | Progressive Motility | 95 % CI | |
Rozhivanov, 2021 | 0.67 | 0.6–0.74 | 0.64 | 0.58–0.7 | |
Elagin, 2021 | 0.2478 | 0.178–0.316 | 0.2376 | 0.159–0.315 | |
Drapkina, 2021 | 0.46 | 0.325–0.58 | 0.455 | 0.28–0.6 | |
Pooled (95 % CI) | 0.43 | 0.24–0.77 | 0.41 | 0.23–0.75 | 0.906 |
I2 | 96.50 % | 95.6 | |||
Normal forms | Normal forms | 95 % CI | Normal forms | 95 % CI | |
Rozhivanov, 2021 | 0.09 | 0.06–0.15 | 0.09 | 0.07–0.15 | |
Elagin, 2021 | 0.07 | 0.05–0.1175 | 0.08 | 0.05–0.15 | |
Drapkina, 2021 | 0.02 | 0.02–0.03 | 0.02 | 0.020.03 | |
Pooled (95 % CI) | 0.05 | 0.02–0.13 | 0.05 | 0.02–0.15 | 0.21 |
I2 | 92 % | 92.1 | |||
FSH levels | FSH levels | 95 % CI | FSH levels | 95 % CI | |
Elagin, 2021 | 5.08 | 2.96–7.20 | 4.88 | 2.43–7.33 | |
Drapkina, 2021 | 4.80 | 3.10–6.40 | 4.80 | 3.20–7.00 | |
Pooled (95 % CI) | 4.91 | 3.98–6.13 | 4.84 | 3.67–6.38 | 0.75 |
I2 | 0.00 % | 0.00 % | |||
LH levels | LH levels | 95 % CI | LH levels | 95 % CI | |
Elagin, 2021 | 4.05 | 3.23–4.6 | 4.10 | 2.92–5.2 | |
Drapkina, 2021 | 3.20 | 2.10–4.36 | 4.30 | 2.60–5.5 | |
Pooled (95 % CI) | 3.76 | 3.04–4.66 | 4.2 | 3.54–4.98 | 0.23 |
I2 | 47.50 % | 0.00 % |